Dasatinib is a novel, potent and multi-targeted inhibitor that targets Abl, Src and c-Kit, with IC50 of <1 nM, 0.8 nM and 79 nM, respectively.Directly targets wild-type and mutant c-Abl kinase domains
Specification: Moligand™, ≥99%
Molecular Formula: C22H26ClN7O2S
Molecular Weight: 488.01
EC Number: 801-607-0
PubChem CID: 3062316
Isomeric SMILES: CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/D125110-SCI_a097512ef6471ce418de5f53db4e068a.pdf
- UPC:
- 41105902
- Condition:
- New
- HazmatClass:
- Yes
- WeightUOM:
- LB
- MPN:
- D125110-200mg
- CAS:
- 302962-49-8
- Health Hazards:
- Carcinogen,Toxic,Corrosive
- Product Size:
- 200mg
- Hazard Statement Codes:
- H361:H372:H410:H318:H351:H301:H315
- Precautionary Statement Codes:
- P501:P405:P362+P364:P305+P351+P338:P302+P352:P391:P330:P280:P273:P270:P264:P260
akash.verma@cenmed.com
(732) 447-1115





